SG11201602066RA - Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation - Google Patents

Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation

Info

Publication number
SG11201602066RA
SG11201602066RA SG11201602066RA SG11201602066RA SG11201602066RA SG 11201602066R A SG11201602066R A SG 11201602066RA SG 11201602066R A SG11201602066R A SG 11201602066RA SG 11201602066R A SG11201602066R A SG 11201602066RA SG 11201602066R A SG11201602066R A SG 11201602066RA
Authority
SG
Singapore
Prior art keywords
choline
derivatives
compositions
processes
preparation
Prior art date
Application number
SG11201602066RA
Inventor
Ran Numa
Gai Ben-Dror
Fabiana Yoseph
Original Assignee
Enzymotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enzymotec Ltd filed Critical Enzymotec Ltd
Publication of SG11201602066RA publication Critical patent/SG11201602066RA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
SG11201602066RA 2013-10-21 2014-10-21 Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation SG11201602066RA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361893307P 2013-10-21 2013-10-21
US201361893308P 2013-10-21 2013-10-21
PCT/IL2014/050912 WO2015059697A1 (en) 2013-10-21 2014-10-21 Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation

Publications (1)

Publication Number Publication Date
SG11201602066RA true SG11201602066RA (en) 2016-04-28

Family

ID=51999472

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201602066RA SG11201602066RA (en) 2013-10-21 2014-10-21 Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation

Country Status (11)

Country Link
US (1) US20160243061A1 (en)
EP (1) EP3060202A1 (en)
JP (1) JP2016535734A (en)
KR (1) KR20160075524A (en)
CN (1) CN105682481A (en)
AU (1) AU2014338503A1 (en)
HK (1) HK1222336A1 (en)
IL (1) IL244484A0 (en)
MX (1) MX2016003207A (en)
SG (1) SG11201602066RA (en)
WO (1) WO2015059697A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3285602A1 (en) * 2015-04-21 2018-02-28 Enzymotec Ltd. Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation
CN108813628A (en) * 2018-05-23 2018-11-16 青岛大学 A kind of preparation method preventing and treating Parkinson's disease edible composition
CN108813453A (en) * 2018-05-23 2018-11-16 青岛大学 A kind of edible composition for preventing and treating Parkinson's disease
US20210212936A1 (en) * 2018-06-01 2021-07-15 Baxter International Inc. Parenteral nutrition formulation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2864848A (en) 1954-07-19 1958-12-16 Ca Nat Research Council Method of producing l-alpha-glycerylphosphorylcholine
US3475177A (en) * 1966-02-09 1969-10-28 Commercial Solvents Corp Choline composition
JPS62111926A (en) * 1985-11-11 1987-05-22 Nippon Oil & Fats Co Ltd Cholinergic nervous system activator
JPH0656671A (en) * 1992-08-04 1994-03-01 Nippon Oil & Fats Co Ltd Functional food
CN1115217A (en) * 1994-07-22 1996-01-24 戴根春 Prodn. method for egg health products
US6013273A (en) * 1997-01-27 2000-01-11 Novartis Nutrition Ag Treatment of endotoxic shock
US20040043013A1 (en) * 2000-12-28 2004-03-04 Mccleary Edward Larry Metabolic uncoupling therapy
US20030206881A1 (en) * 2001-05-31 2003-11-06 Peter Fussbroich Phospholipidic composition as well as the use thereof
EP1875816A3 (en) * 2003-07-10 2008-03-12 Carl A. Forest Beverages with specialized supplements
JP4933432B2 (en) 2005-07-19 2012-05-16 旭化成ファーマ株式会社 New phospholipid processing agent
JP5300186B2 (en) * 2006-08-23 2013-09-25 株式会社明治 Milk-derived composition for pregnant women that suppresses increase in homocysteine concentration in blood
EP2076244B1 (en) * 2006-10-10 2016-12-07 Jina Pharmaceuticals Inc. Aqueous systems for the preparation of lipid-based pharmaceutical compounds; compositions, methods, and uses thereof
CA2609580A1 (en) * 2006-12-06 2008-06-06 H3 Formulations Ltd. Composition for promoting cognitive attributes
JP2009155337A (en) * 2009-03-31 2009-07-16 Tsujido Chemical Corp Treating agent
JP6043064B2 (en) * 2009-06-16 2016-12-14 株式会社明治 A milk-derived composition for pregnant women that prevents the risk of reduced birth weight in babies
WO2012090713A1 (en) * 2010-12-29 2012-07-05 株式会社西崎創薬研究所 Concomitant drug for improving cognitive function
ITGE20110050A1 (en) * 2011-04-29 2012-10-30 Marco Zipoli FOOD, IN PARTICULAR A DRINK FOR HUMAN CONSUMPTION
CN102516292B (en) * 2011-11-08 2014-09-10 西北大学 Natural L-alpha-glycerophosphocholine (GPC) and preparation method thereof
CN102964377B (en) * 2012-11-30 2015-05-27 西北大学 Method for preparing natural L-alpha-glycerol phosphatidylcholine
EP2859889A1 (en) * 2013-10-14 2015-04-15 Abbott Laboratories Compositions and methods for improving cognitive function

Also Published As

Publication number Publication date
HK1222336A1 (en) 2017-06-30
IL244484A0 (en) 2016-04-21
US20160243061A1 (en) 2016-08-25
EP3060202A1 (en) 2016-08-31
WO2015059697A1 (en) 2015-04-30
CN105682481A (en) 2016-06-15
MX2016003207A (en) 2016-08-11
KR20160075524A (en) 2016-06-29
AU2014338503A1 (en) 2016-03-31
JP2016535734A (en) 2016-11-17

Similar Documents

Publication Publication Date Title
IL285390A (en) Arylquinazolines, their preparation and pharmaceutical compositions containing them
IL288961A (en) Pharmaceutical compositions
IL243752B (en) Multispecific antibodies, compositions comprising same and uses thereof
IL241355A0 (en) Pyrazole-amide compounds, compositions comprising same and uses yhereof
PL2943181T3 (en) Pharmaceutical compositions
HK1222563A1 (en) Pharmaceutical composition, preparation and uses thereof
HK1210806A1 (en) Method for manufacturing immunocyte-containing composition, and cancer-treating composition
ZA201408333B (en) Pharmaceutical compositions
IL246406A0 (en) Imidazopyrazinone derivatives, their preparation and pharmaceutical compositions containing them
HK1216839A1 (en) Modified release formulation
EP2941418A4 (en) N1-cyclic amine-n5-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same
HK1222336A1 (en) Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation
IL233682A0 (en) Substituted phenylazole derivatives, compositions comprising same and uses thereof
IL239873B (en) Piperidinylcarbazole derivatives, their preparation and pharmaceutical compositions containing them
IL239874A0 (en) Acylguanidine derivatives, their preparation and pharmaceutical compositions containing them
HRP20171888T1 (en) Pharmaceutical compositions
EP3057972A4 (en) Novel compositions, uses and methods for their preparation
EP2945703A4 (en) Formulations of albu-bche, preparation and uses thereof
IL284405A (en) Pharmaceutical composition, preparation and uses thereof
GB201304699D0 (en) Pharmaceutical compositions
GB201321497D0 (en) Pharmaceutical compositions
GB201312851D0 (en) Pharmaceutical compositions